5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.83▼ | 3.88▼ | 3.88▼ | 3.77▼ | 3.59▲ |
MA10 | 4.01▼ | 4.07▼ | 4.11▼ | 3.49▲ | 5.15▼ |
MA20 | 4.27▼ | 4.28▼ | 3.99▼ | 3.61▲ | 6.49▼ |
MA50 | 4.01▼ | 3.65▲ | 3.58▲ | 5.46▼ | 6.39▼ |
MA100 | 3.70▲ | 4.07▼ | 4.58▼ | 6.51▼ | 7.80▼ |
MA200 | 4.64▼ | 5.47▼ | 5.82▼ | 6.37▼ | 29.30▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.099▼ | -0.111▼ | -0.073▼ | 0.189▲ | -0.498▼ |
RSI | 36.253▼ | 42.233▼ | 45.971▼ | 42.255▼ | 37.806▼ |
STOCH | 4.282▼ | 3.833▼ | 6.677▼ | 51.383 | 5.239▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -61.165 | -90.338▼ |
CCI | -117.304▼ | -124.296▼ | -130.351▼ | 76.877 | -87.896 |
Monday, April 28, 2025 05:00 PM
ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...
|
Monday, April 28, 2025 05:00 PM
ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...
|
Monday, April 14, 2025 05:00 PM
European stocks started the day on May 21 with a slightly weaker note, marking a retreat from their recent impressive performance, with attention now shifting towards the upcoming earnings report ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 3.84 | 4.01 | 3.70 | 3.72 | 27,482 |
30/04/25 | 4.30 | 4.40 | 3.75 | 3.97 | 184,666 |
29/04/25 | 3.735 | 4.98 | 3.735 | 4.39 | 580,211 |
28/04/25 | 3.24 | 3.64 | 3.19 | 3.57 | 57,187 |
25/04/25 | 3.19 | 3.25 | 3.1135 | 3.18 | 34,672 |
24/04/25 | 3.20 | 3.56 | 3.20 | 3.30 | 89,829 |
23/04/25 | 3.05 | 3.39 | 3.05 | 3.12 | 57,778 |
22/04/25 | 3.20 | 3.3055 | 2.92 | 2.945 | 66,089 |
21/04/25 | 3.45 | 3.45 | 3.2111 | 3.29 | 19,273 |
17/04/25 | 3.48 | 3.54 | 3.40 | 3.455 | 13,667 |
|
|
||||
|
|
||||
|
|